Jak, Janus kinase
<p>Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors</p>
9
Type I interferonopathies in pediatric rheumatology
12
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
6
Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel STAT5b Gene Mutation
11
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
8
In silico docking analysis of Janus kinase enzymes and phytochemicals
7
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
6
Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
15
Sphingosine 1-Phosphate-Metabolizing Enzymes Control Influenza Virus Propagation and Viral Cytopathogenicity
8
Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren’s syndrome uncovered through gene expression meta analysis
8
Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
7
JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
5
Mitogen-Activated Protein Kinase Kinase 2, a Novel E2-Interacting Protein, Promotes the Growth of Classical Swine Fever Virus via Attenuation of the JAK-STAT Signaling Pathway
14
Role of janus kinase inhibitors in the treatment of alopecia areata
13
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
9
Checkpoint inhibitors in hematological malignancies
16
CP690,550 inhibits oncostatin M induced JAK/STAT signaling pathway in rheumatoid synoviocytes
10
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2
7
α Lipoic Acid Inhibits Expression of IL 8 by Suppressing Activation of MAPK, Jak/Stat, and NF κB in H pylori Infected Gastric Epithelial AGS Cells
5
A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation
5